Tu banner alternativo

Ethylpropyltryptamine

The Ethylpropyltryptamine theme is a theme that has captured the interest of many people over time. Since its emergence, Ethylpropyltryptamine has been the subject of debates, discussions and numerous investigations. Its relevance extends to different fields, since it has an impact on society, the economy, technology and many other areas. Ethylpropyltryptamine is a topic that has evolved and adapted to social and cultural changes, always remaining at the forefront of public attention. In this article, we will explore the different aspects of Ethylpropyltryptamine and its importance in today's world.

Tu banner alternativo

Ethylpropyltryptamine
Clinical data
Other namesEPT; N-Ethyl-N-propyltryptamine
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • N-ethyl-N-propan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H22N2
Molar mass230.355 g·mol−1
3D model (JSmol)
  • CCCN(CC)CCC1=CNC2=CC=CC=C12
  • InChI=1S/C15H22N2/c1-3-10-17(4-2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
  • Key:LCDYRMYSOIVPRS-UHFFFAOYSA-N

Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug in the tryptamine family. It has been identified in illicit products in Japan.[1]

Use and effects

EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[2]

Interactions

Chemistry

Analogues

Analogues of EPT include methylethyltryptamine (MET), methylpropyltryptamine (MPT), diethyltryptamine (DET), dipropyltryptamine (DPT), among others.[2]

Society and culture

United Kingdom

It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016.[3]

United States

EPT is unscheduled but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.

See also

References

  1. ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (January 2021). "Identification of six tryptamine derivatives as designer drugs in illegal products". Forensic Toxicology. 39 (1): 248–258. doi:10.1007/s11419-020-00556-5.
  2. ^ a b Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
  3. ^ "Misuse of Drugs Act 1971". Legislation.gov.uk.